Hydrazide compounds
US6271247A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2000 |
| Grant date | Aug 7, 2001 |
| Priority date | — |
| Expiry date | Jun 23, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I): EQU R--NH--A--CO--NH--NH--(W).sub.n --Z (I) wherein: PA1 n is 0 or 1, PA1 W represents --CO-- or S(O).sub.r wherein r is 0, 1 or 2, PA1 Z represents a group selected from aryl, arylalkyl, heteroaryl and heteroarylalkyl, each optionally substituted, PA1 R represents a grouping selected from: PA2 Z.sub.1 --T--CO--, Z.sub.1 --O--T--CO--, Z.sub.1 --T--O--CO--, Z.sub.1 --T--S(O).sub.q -- PA2 wherein Z.sub.1, T and q are as defined in the description, PA1 A represents alkylene, alkenylene or alkynylene each having from 3 to 8 carbon atoms, alkylenecycloalkylene, cycloalkylenealkylene, alkylenecycloalkylenealkylene, alkylenearylene, arylenealkylene, alkylenearylenealkylene a grouping ##STR1## wherein B.sub.1 is as defined in the description, or A forms with the adjacent nitrogen atom a grouping ##STR2## as defined in the description. Medicinal products containing the same are useful as Neuropeptide Y receptors ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.